The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells
Open Access
- 1 May 1997
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 115 (1) , 73-79
- https://doi.org/10.1016/s0304-3835(97)04716-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Recent advances in annonaceous acetogeninsNatural Product Reports, 1996
- P-Glycoprotein: Clinical Significance and Methods of AnalysisCritical Reviews in Clinical Laboratory Sciences, 1995
- Mode of action of bullatacin, a potent antitumor acetogenin: Inhibition of NADH oxidase activity of HELA and HL-60, but not liver, plasma membranesLife Sciences, 1994
- A mechanism for P-glycoprotein action in multidrug resistance: are we there yet?Trends in Pharmacological Sciences, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Inhibition of Respiration at Site I by Asimicin, an Insecticidal Acetogenin of the Pawpaw, Asimina triloba (Annonaceae)Pesticide Biochemistry and Physiology, 1993
- Mode of action of bullatacin: A potent antitumor and pesticidal Annonaceous acetogeninLife Sciences, 1993
- Annonaceous acetogenins: An updated reviewPhytochemical Analysis, 1993
- Molecular mode of action of annoninsPesticide Science, 1991
- Annonaceous Acetogenins: A ReviewJournal of Natural Products, 1990